Skip to main content
Clinical Trials/ISRCTN14084189
ISRCTN14084189
Active, Not Recruiting
N/A

Clinical trial aimed to evaluate the efficacy of a food supplement in managing stress in university students: a double-blind, placebo-controlled, cross-over study

ROELMI HPC Srl0 sites42 target enrollmentJanuary 26, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stress
Sponsor
ROELMI HPC Srl
Enrollment
42
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2024
End Date
April 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ROELMI HPC Srl

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy male and female subjects
  • 2\. Caucasian ethnicity
  • 3\. Age more than 18 years old (included)
  • 4\. Attending university and will have at least two exams per examination session
  • 5\. Not addicted to smoking and drinking
  • 6\. Have not been recently involved in any other similar study (at least 2 months of wash\-out)
  • 7\. Under effective contraception (oral/not oral) therapy
  • 8\. Able to comply with the protocol and follow the protocol’s constraints and specific requirements
  • 9\. Commitment to use during the entire study period only the products to be tested
  • 10\. Commitment to not use products likely to interfere with the product to be tested

Exclusion Criteria

  • 1\. Does not meet the inclusion criteria
  • 2\. Pathological psychological conditions related or not related to stress
  • 3\. Known hypersensitivity or allergy to one of the active ingredients
  • 4\. Any condition that the principal investigator deems inappropriate for participation
  • 5\. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential)
  • 6\. Subject with known or suspected food intolerance or food allergy
  • 7\. Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications
  • 8\. Pharmacological treatments (antidepressant, anxiolytic, psychotropic drugs, etc) known to interfere with the tested product
  • 9\. Severe concurrent diseases
  • 10\. Subjects with a history of drug, alcohol and other substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials